The fraction of total circulating hormones, such as testosterone or estrogen, that is unbound by plasma proteins like SHBG or albumin and is therefore free to interact with cellular receptors. This metric provides a more accurate assessment of the hormonal signal available to target tissues than total hormone measurements alone. Clinically, this status directly correlates with physiological effect and symptom presentation. Understanding this availability is crucial for assessing endocrine function.
Origin
This concept arises from endocrinology, specifically acknowledging that hormone transport in the bloodstream is largely protein-mediated, necessitating a distinction between bound and unbound fractions for true biological relevance. The term integrates principles of endocrinology and pharmacokinetics to define active concentration. Its evolution reflects a move toward more nuanced assessments beyond simple total hormone assays.
Mechanism
Hormones circulate predominantly bound to carrier proteins, rendering them biologically inert until dissociation occurs. The bioavailable fraction represents the unbound or loosely bound molecules capable of diffusing into cells to initiate genomic or non-genomic signaling cascades. Maintaining an optimal ratio of free to bound hormone is essential for downstream cellular responsiveness and maintaining homeostasis. This dynamic equilibrium dictates the actual level of endocrine activity within the body’s systems.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.